REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Human Genome Sciences Names Tuomo Pätsi Vice President, HGS Europe
August 13, 2010
from Business Wire News Releases
EHSI Advances to Finalize Deal with Stand-By Systems
August 02, 2010
from Business Wire News Releases
Analytical Reports on Human Genome Science and Genzyme -- Biotech Stocks Under Stress
July 28, 2010
from Marketwired News Releases
Human Genome Sciences Announces Second Quarter 2010 Financial Results and Key Developments
July 22, 2010
BENLYSTA® Regulatory Applications Submitted in United States, Europe and Canada Read More
from Business Wire News Releases
Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma
July 19, 2010
from PR Newswire
Human Genome Sciences and Lonza Enter Commercial Manufacturing Agreement for BENLYSTA®, a Potential New Treatment for Systemic Lupus Erythematosus
July 13, 2010
from Business Wire News Releases
Human Genome Sciences and Lonza Enter Commercial Manufacturing Agreement for BENLYSTA®, a Potential New Treatment for Systemic Lupus Erythematosus
July 13, 2010
from Business Wire News Releases
Human Genome Sciences Announces Presentation of Additional Phase 3 SLE Study Results for BENLYSTA® (Belimumab) at International Congress on SLE
June 25, 2010
from Business Wire News Releases
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at NASDAQ OMX 24th Investor Program
June 21, 2010
from Business Wire News Releases
Wall Street News Alert: Trade Alert: UYMG - June 18, 2010
June 18, 2010
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding. Read More
from Marketwired News Releases
Human Genome Sciences and GlaxoSmithKline Announce Presentation at EULAR of BLISS-52 Phase 3 SLE Study Results for BENLYSTA® (belimumab)
June 17, 2010
- Poster presentations at EULAR of data from the BLISS-52 study in patients with seropositive systemic lupus erythematosus (SLE) will report that belimumab, compared with placebo in this study,... Read More
from Business Wire News Releases
Human Genome Sciences and GlaxoSmithKline Announce Full Presentation at EULAR of BLISS-76 Phase 3 Study Results for BENLYSTA® in Systemic Lupus Erythematosus
June 17, 2010
from Business Wire News Releases
Human Genome Sciences and GlaxoSmithKline Announce Presentation at EULAR of BLISS-52 Phase 3 SLE Study Results for BENLYSTA® (belimumab)
June 17, 2010
- Poster presentations at EULAR of data from the BLISS-52 study in patients with seropositive systemic lupus erythematosus (SLE) will report that belimumab, compared with placebo in this study,... Read More
from Business Wire News Releases
Human Genome Sciences and GlaxoSmithKline Announce Full Presentation at EULAR of BLISS-76 Phase 3 Study Results for BENLYSTA® in Systemic Lupus Erythematosus
June 17, 2010
from Business Wire News Releases
Human Genome Sciences Announces Preliminary Feedback From FDA on ZALBIN™ BLA for Chronic Hepatitis C
June 14, 2010
from Business Wire News Releases
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Goldman Sachs Healthcare Conference
June 11, 2010
from Business Wire News Releases
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Analyst & Investor Meeting
June 10, 2010
from Business Wire News Releases
Human Genome Sciences Announces Submission of Biologics License Application to FDA for BENLYSTA® (belimumab)
June 10, 2010
from Business Wire News Releases
Human Genome Sciences Announces Results of Randomized Phase 2 Trial of Mapatumumab in Multiple Myeloma
June 09, 2010
from Business Wire News Releases
Human Genome Sciences Announces Submission of Marketing Authorization Application to EMA for BENLYSTA® (Belimumab)
June 07, 2010
from Business Wire News Releases
Critical Alerts for American Express, Gap, Patriot Coal, Human Genome Sciences, and Royal Bank of Canada Released by Seven Summits Research
June 03, 2010
from PR Newswire
Dendreon Announces Election of Dr. David C. Stump to Board of Directors
June 02, 2010
from PR Newswire
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Citi Health Care Conference
May 24, 2010
from Business Wire News Releases
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bank of America Merrill Lynch Health Care Conference
May 07, 2010
from Business Wire News Releases
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Deutsche Bank Health Care Conference
April 29, 2010
from Business Wire News Releases
Human Genome Sciences Announces First Quarter 2010 Financial Results and Key Developments
April 29, 2010
Submission of BENLYSTA™ regulatory applications in the United States and Europe planned second quarter 2010 Read More
from Business Wire News Releases
Critical Alerts for eBay, Dow Chemical, Archer Daniels Midland, Human Genome Sciences, and L-3 Communications Released by Seven Summits Research
April 28, 2010
from PR Newswire
Zacks Analyst Blog Highlights: Human Genome Sciences Inc., Novartis AG, Merck, Roche and GlaxoSmithKline plc
April 21, 2010
from Business Wire News Releases
Complimentary Analyst Research on Sirius XM Radio, Inc. (NASDAQ: SIRI), Human Genome Sciences, Inc. (NASDAQ: HGSI), US Bancorp (NYSE: USB), Johnson & Johnson (NYSE: JNJ) and Many More Available at Bed
April 20, 2010
Note to Editors: The Following Is an Investment Opinion Being Issued by The Bedford Report Read More
from Marketwired News Releases
Human Genome Sciences and GlaxoSmithKline Announce Topline 76-Week Results of Phase 3 Trial of BENLYSTA™ in Systemic Lupus Erythematosus
April 20, 2010
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here